Drawing for STRAVENCON

USPTO serial 79097290

STRAVENCON

Reviewed by CopyMark Law Group

Reg. 4103838Status 404
Filing date
Status date
Registration date
Feb 28, 2012
Examiner
HAN, DAWN L
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with STRAVENCON?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, anti-bacterial, anti-diabetic, anti-viral, anti-sickness, anti-infective and cardiovascular treatment pharmaceuticals, anti-allergic pharmaceutical preparations, pharmaceutical preparations for the treatment of infectious diseases and disorders of the central nervous system, pharmaceutical preparations for hormonal deficiencies, erectile dysfunction and reproductive dysfunction, pharmaceutical preparations for use in oncology; veterinary preparations, namely, therapeutic anti-infective, anti-bacterial, anti-sickness and anti-allergic pharmaceuticals and therapeutic veterinary preparations, namely, pharmaceuticals for the treatment of infectious diseases, hormonal deficiencies and for use in oncology, all for livestock and domestic animals; sanitary preparations for medical purposes; dietetic foods adapted for medical use; material for stopping teeth; vaccinesSECTION 71 - CANCELLED
010Surgical, medical, veterinary and dental devices, apparatus and instruments, namely, drug delivery systems, knives for surgical use, lasers for surgical and medical use, catheters for surgical use, and surgical and medical apparatus and instruments for use in general surgery; artificial limbs, eyes and teeth; orthopedic articles, namely, orthopedic apparatus and instruments for diagnostic and therapeutic use; suture materialsSECTION 71 - CANCELLED
035Marketing services, namely, promoting or advertising the goods and services of others; marketing support services, namely, advertising and marketing of pharmaceutical and diagnostic preparations, therapeutics, medical apparatus, instruments and devices of third parties to enable them to be accepted and sold for worldwide distribution; creation of marketing partnerships between companies, namely, cooperative advertising and marketing of pharmaceutical companies as partners and their intellectual property licenses for the regulatory acceptance and sale of pharmaceuticals, medical apparatus, instruments and devices for worldwide distribution; advertising agencies; business development; consultation in the field of sales promotion services for business purposes; sourcing in the nature of procurement, namely, purchasing for others pharmaceutical products and medical apparatus, instruments and devices from third parties for worldwide distribution; import and export agencies; business auditing and preparation of business reports in the field of pharmaceutical products, and medical apparatus, instruments and device, for the purpose of regulatory guidance; executive recruiting services of management staff and personnel for pharmaceuticals and life sciences companies; business advisory and management services relating to company acquisitions and identifying and negotiating company acquisitions for third parties; business management and advisory services relating to obtaining marketing authorisations from relevant governing authorities in respect of pharmaceutical products, medical apparatus, instruments and devices; computerised database management; compilation and systemization of information into computer databases; commercial information agencies featuring a computer database; all of the aforesaid also provided online via the Internet or other interactive electronic platforms; information, advisory and consultancy services relating to all of the aforesaidSECTION 71 - CANCELLED
039Warehousing services, namely, storage, distribution, pick-up, packing, and shipping of pharmaceutical products and medical apparatus, instruments and devices; information, advisory and consultancy services relating to the aforesaidSECTION 71 - CANCELLED
045Licensing of pharmaceutical products; licensing of intellectual property for research and development purposes; licensing of intellectual property relating to pharmaceutical products, medical apparatus, instruments and devices; providing regulatory compliance information in the field of pharmaceuticals, medical devices, apparatus and instruments; information, advisory and consultancy services relating to all of the aforesaidSECTION 71 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 11, 2021WOAGWITHDRAWAL OF ATTORNEY GRANTED
Nov 11, 2021WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED
Nov 2, 2021DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 2, 2021DETHDEATH OF INTERNATIONAL REGISTRATION
Nov 30, 2019INNTTOTAL INVALIDATION PROCESSED BY THE IB
Jun 28, 2019INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 28, 2019INPCINVALIDATION PROCESSED
Jun 5, 2019INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 5, 2018C71TCANCELLED SECTION 71
Feb 28, 2017REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 20, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED
Feb 26, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED
Nov 14, 2014NREPNEW REPRESENTATIVE AT IB RECEIVED
Dec 13, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED
Nov 15, 2012FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Oct 19, 2012FICSFINAL DISPOSITION NOTICE SENT TO IB
Oct 19, 2012FIMPFINAL DISPOSITION PROCESSED
Jul 1, 2012GPNXNOTIFICATION PROCESSED BY IB
May 28, 2012FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 28, 2012R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Dec 13, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 13, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 23, 2011OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 23, 2011OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 23, 2011NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 4, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 4, 2011ALIEASSIGNED TO LIE
Oct 9, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Sep 14, 2011XAECEXAMINER'S AMENDMENT ENTERED
Sep 14, 2011GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 14, 2011GNEAEXAMINERS AMENDMENT E-MAILED
Sep 14, 2011CNEAEXAMINERS AMENDMENT -WRITTEN
Aug 20, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 19, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 19, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 4, 2011RFNTREFUSAL PROCESSED BY IB
Jun 14, 2011MAFRAPPLICATION FILING RECEIPT MAILED
Jun 13, 2011RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 13, 2011RFRRREFUSAL PROCESSED BY MPU
Jun 12, 2011RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 11, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 10, 2011DOCKASSIGNED TO EXAMINER
Jun 10, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 9, 2011LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 9, 2011REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance